Insider trading

Period: 120 months Stock: IONS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

463 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

463 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

463 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

463 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
463 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
463 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

463 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
30 Sep 2025
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold on a plan
$3.25M 49,800 at 65.26
31.1%
Planned (10b5-1)
30 Sep 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$958.98K 14,827 at 64.68
20.6%
Planned (10b5-1)
29 Sep 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$675.95K 10,473 at 64.54
15.5%
Planned (10b5-1)
12 Sep 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$109.79K 1,700 at 64.58
2.9%
Planned (10b5-1)
9 Sep 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan 2×
$1.36M 21,000 at 64.56
26.9%
Planned (10b5-1)
9 Sep 2025
Baroldi Joseph EVP, Chief Business Officer
Sold on a plan
$742.84K 11,950 at 62.16
27.2%
Planned (10b5-1)
5 Sep 2025
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$357.58K 6,000 at 59.60
6.8%
Planned (10b5-1)
5 Sep 2025
Baroldi Joseph EVP, Chief Business Officer
Sold on a plan
$15.50K 250 at 62.00
0.8%
Planned (10b5-1)
3 Sep 2025
Monia Brett P Chief Executive Officer
Sold at will 3×
$12.29M 203,814 at 60.32
53.1%
Sold half or more
3 Sep 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan 2×
$4.69M 76,850 at 60.97
93.1%
Sold half or more
3 Sep 2025
KLEIN JOSEPH III Director · indirect
Sold on a plan 2×
$3.36M 56,000 at 60.00
100%
Sold half or more
3 Sep 2025
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$2.06M 33,909 at 60.62
25.0%
Planned (10b5-1)
3 Sep 2025
Baroldi Joseph EVP, Chief Business Officer
Sold on a plan 2×
$1.95M 32,800 at 59.34
66.0%
Sold half or more
3 Sep 2025
WENDER JOSEPH H Director · indirect
Sold on a plan 2×
$1.35M 22,400 at 60.14
17.1%
Planned (10b5-1)
3 Sep 2025
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold on a plan 2×
$1.20M 19,658 at 60.81
27.6%
Planned (10b5-1)
3 Sep 2025
LOSCALZO JOSEPH Director
Sold at will
$962.37K 16,000 at 60.15
30.6%
Not planned
3 Sep 2025
Devers Shannon L. EVP, Chief Human Resources Ofc
Sold on a plan
$192.94K 3,162 at 61.02
17.4%
Planned (10b5-1)
2 Sep 2025
WENDER JOSEPH H Director · indirect
Sold on a plan 4×
$1.88M 33,600 at 55.87
21.9%
Planned (10b5-1)
2 Sep 2025
PARSHALL B LYNNE Director
Sold on a plan 2×
$1.02M 20,000 at 50.91
23.2%
Planned (10b5-1)
2 Sep 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$711.42K 13,050 at 54.51
18.6%
Planned (10b5-1)
2 Sep 2025
Swayze Eric EVP Research
Sold on a plan 2×
$552.86K 11,130 at 49.67
23.0%
Planned (10b5-1)
2 Sep 2025
Geary Richard S EVP, Chief Development Officer
Sold on a plan
$503.67K 10,000 at 50.37
11.2%
Planned (10b5-1)
2 Sep 2025
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$245.70K 5,000 at 49.14
5.3%
Planned (10b5-1)
22 Aug 2025
Diaz Allene M. Director
Sold on a plan
$60.69K 1,427 at 42.53
7.2%
Planned (10b5-1)
18 Aug 2025
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$439.78K 10,000 at 43.98
9.7%
Planned (10b5-1)
6 Aug 2025
PARSHALL B LYNNE Director
Sold on a plan 2×
$209.65K 5,000 at 41.93
5.5%
Planned (10b5-1)
5 Aug 2025
Geary Richard S EVP, Chief Development Officer
Sold on a plan
$428.59K 10,000 at 42.86
10.1%
Planned (10b5-1)
4 Aug 2025
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold on a plan
$408.70K 9,549 at 42.80
15.6%
Planned (10b5-1)
30 Jul 2025
Monia Brett P Chief Executive Officer
Sold on a plan
$109.44K 2,432 at 45.00
1.3%
Planned (10b5-1)
11 Jul 2025
Monia Brett P Chief Executive Officer
Sold on a plan
$48.42K 1,160 at 41.74
0.6%
Planned (10b5-1)
1 May 2025
Hayden Michael R Director
Bought
$477.90K 15,000 at 31.86
42.6%
Largest buy in 3 yrs
16 Apr 2025
Baroldi Joseph EVP, Chief Business Officer
Sold at will
$111.56K 3,928 at 28.40
11.0%
Not planned
16 Apr 2025
Jenne Kyle EVP, Chf GL Pdt Str Ofcr
Sold at will
$85.53K 3,016 at 28.36
21.2%
Not planned
16 Apr 2025
Birchler Brian EVP, Corp and Development Ops
Sold at will
$19.29K 680 at 28.37
1.2%
Not planned
11 Mar 2025
Monia Brett P Chief Executive Officer
Sold on a plan
$4.52K 140 at 32.32
0.1%
Planned (10b5-1)
20 Feb 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$39.05K 1,207 at 32.35
2.1%
Planned (10b5-1)
4 Feb 2025
Monia Brett P Chief Executive Officer
Sold on a plan
$1.23M 38,843 at 31.65
17.7%
Planned (10b5-1)
4 Feb 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$194.94K 6,165 at 31.62
9.7%
Planned (10b5-1)
31 Jan 2025
Monia Brett P Chief Executive Officer
Sold at will
$429.66K 13,242 at 32.45
5.7%
Not planned
31 Jan 2025
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold at will
$49.40K 1,523 at 32.44
1.4%
Not planned
31 Jan 2025
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold at will
$47.78K 1,484 at 32.20
2.4%
Not planned
31 Jan 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold at will
$45.68K 1,406 at 32.49
2.2%
Not planned
31 Jan 2025
Geary Richard S EVP, Chief Development Officer
Sold at will
$45.56K 1,406 at 32.40
1.4%
Not planned
31 Jan 2025
Swayze Eric EVP Research
Sold at will
$44.16K 1,367 at 32.31
2.8%
Not planned
31 Jan 2025
BENNETT C FRANK EVP, Chief Scientific Officer
Sold at will
$43.08K 1,327 at 32.46
1.4%
Not planned
16 Jan 2025
Monia Brett P Chief Executive Officer
Sold at will
$1.09M 33,445 at 32.63
13.9%
Not planned
16 Jan 2025
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold at will
$290.99K 8,870 at 32.81
7.6%
Not planned
16 Jan 2025
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold at will
$241.63K 7,360 at 32.83
10.7%
Not planned
16 Jan 2025
Swayze Eric EVP Research
Sold at will
$234.96K 7,154 at 32.84
13.5%
Not planned
16 Jan 2025
Geary Richard S EVP, Chief Development Officer
Sold at will
$232.41K 7,072 at 32.86
6.8%
Not planned
Showing 101–150 of 463. ← Newer Page 3 of 10 Older →